ORAI1 and cancer: Furthermore, alterations in Orai1 glycosylation have been observed in cancer cells and overexpression of the enzyme β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) has been reported to play a relevant role in cancer invasiveness and metastasis.